Yanling Zhao Selected Research

zuojin

3/2022	Zuojin Pill attenuates Helicobacter pylori-induced chronic atrophic gastritis in rats and improves gastric epithelial cells function in GES-1 cells.
1/2022	Efficacy and Safety of Zuojin Pill for the Treatment of Chronic Nonatrophic Gastritis: A Randomized Active-Controlled Clinical Trial.
7/2021	Zuojin Pill ameliorates inflammation in indomethacin-induced gastric injury via inhibition of MAPK pathway.
5/2021	Zuojin Pill ameliorates chronic atrophic gastritis induced by MNNG through TGF-β1/PI3K/Akt axis.
1/2021	Metabolomic Study of Zuojin Pill in Relieving 1-Methyl-3-nitro-1-nitrosoguanidine-Induced Chronic Atrophic Gastritis.
1/2021	Based on Network Pharmacology to Explore the Potential Bioactive Compounds and Mechanisms of Zuojin Pill for the Treatment of Ulcerative Colitis.
1/2015	Biothermodynamic Assay of Coptis-Evodia Herb Couples.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yanling Zhao Research Topics

Disease

33	Neoplasms (Cancer) 07/2022 - 06/2007
18	Inflammation (Inflammations) 01/2022 - 06/2007
16	Neuroblastoma 10/2019 - 10/2013
13	Cholestasis 01/2021 - 03/2012
11	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 11/2014
11	Heart Failure 01/2021 - 08/2017
9	Atrophic Gastritis 03/2022 - 01/2020
7	Fibrosis (Cirrhosis) 01/2022 - 11/2014
5	Liver Diseases (Liver Disease) 01/2022 - 12/2014
5	Infections 01/2021 - 11/2017
5	Breast Neoplasms (Breast Cancer) 01/2019 - 06/2008
4	Body Weight (Weight, Body) 07/2021 - 08/2013
4	Non-alcoholic Fatty Liver Disease 01/2021 - 01/2020
4	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 07/2016
4	Hepatitis 01/2020 - 03/2012
3	Cough 08/2022 - 01/2021
3	Respiratory Sounds (Crackle) 08/2022 - 01/2021
3	Ulcerative Colitis 06/2022 - 01/2021
3	Carcinogenesis 01/2022 - 11/2017
3	Chronic Hepatitis B 01/2021 - 01/2015
2	Acute Kidney Injury (Acute Renal Failure) 04/2022 - 11/2020
2	Gastritis 01/2022 - 01/2015
2	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 01/2022 - 09/2021
2	Necrosis 08/2021 - 05/2017
2	Alzheimer Disease (Alzheimer's Disease) 08/2021 - 01/2014
2	Stomach Ulcer (Gastric Ulcer) 06/2021 - 01/2020
2	Insulin Resistance 01/2021 - 01/2020
2	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 07/2015
2	Lung Neoplasms (Lung Cancer) 01/2021 - 06/2008
2	Cardiac Arrhythmias (Arrythmia) 01/2021 - 06/2019
2	Reperfusion Injury 01/2021 - 08/2019
2	Neoplasm Metastasis (Metastasis) 01/2020 - 07/2019
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 01/2016
2	Hyperplasia 10/2019 - 01/2018
2	Bacterial Infections (Bacterial Infection) 07/2019 - 01/2019
2	Mitochondrial Diseases (Mitochondrial Disease) 07/2019 - 01/2019
2	Autoimmune Hepatitis 06/2019 - 01/2018
2	Cardiovascular Diseases (Cardiovascular Disease) 06/2019 - 12/2018
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2017 - 05/2017

Drug/Important Bio-Agent (IBA)

18	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2020 - 10/2013
15	Therapeutic UsesIBA 10/2021 - 01/2016
10	Pharmaceutical PreparationsIBA 01/2021 - 01/2015
9	Proteins (Proteins, Gene)FDA Link 07/2022 - 01/2014
9	Bile Acids and Salts (Bile Acids)IBA 01/2021 - 08/2013
9	peoniflorinIBA 01/2021 - 03/2012
7	zuojinIBA 03/2022 - 01/2015
6	Anti-Bacterial Agents (Antibiotics)IBA 08/2022 - 01/2017
6	BerberineIBA 06/2022 - 05/2020
6	Biological ProductsIBA 01/2021 - 12/2017
6	Proteasome InhibitorsIBA 01/2019 - 01/2016
5	Interleukin-6 (Interleukin 6)IBA 08/2021 - 01/2020
5	higenamine (norcoclaurine)IBA 01/2021 - 01/2019
4	Long Noncoding RNAIBA 07/2022 - 12/2017
4	Sirtuin 1IBA 01/2021 - 08/2017
4	GlycosidesIBA 01/2021 - 01/2020
4	gingerolIBA 11/2020 - 01/2019
4	Phosphotransferases (Kinase)IBA 10/2019 - 01/2017
4	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2019 - 01/2016
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2015
3	Caspase 3 (Caspase-3)IBA 01/2021 - 11/2017
3	yinchenhaoIBA 01/2021 - 06/2015
3	Alanine Transaminase (SGPT)IBA 01/2021 - 01/2014
3	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021 - 01/2014
3	Sevoflurane (Ultane)FDA LinkGeneric 01/2020 - 08/2019
3	ginger extractIBA 06/2019 - 08/2017
3	fuzi drug herbalIBA 12/2017 - 05/2014
3	1-Naphthylisothiocyanate (1 Naphthylisothiocyanate)IBA 05/2017 - 03/2012
3	BilirubinIBA 04/2015 - 08/2013
2	tanreqingIBA 08/2022 - 01/2021
2	huanglian-jie-du decoctionIBA 01/2022 - 01/2021
2	ChromatinIBA 10/2021 - 07/2015
2	rutecarpineIBA 06/2021 - 01/2020
2	Ethanol (Ethyl Alcohol)IBA 06/2021 - 01/2020
2	Methylnitronitrosoguanidine (MNNG)IBA 05/2021 - 01/2021
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 08/2011
2	NF-kappa B (NF-kB)IBA 01/2021 - 05/2017
2	AntipyreticsIBA 01/2021 - 01/2020
2	kusheninIBA 01/2021 - 01/2015
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 08/2019
2	Monoterpenes (Monoterpenoids)IBA 01/2021 - 01/2020
2	Nonprescription Drugs (Patent Medicines)IBA 01/2021 - 12/2018
2	Epidermal Growth Factor (EGF)IBA 01/2021 - 01/2017
2	entecavir FDA Link 01/2021 - 01/2020
2	AlkaloidsIBA 12/2020 - 06/2020
2	palmatineIBA 09/2020 - 01/2020
2	AcidsIBA 06/2020 - 06/2008
2	Antiviral Agents (Antivirals)IBA 01/2020 - 02/2014
2	Etoposide (VP 16)FDA LinkGeneric 01/2019 - 10/2013
2	delanzomibIBA 01/2019 - 12/2017
2	San-Cao granulesIBA 01/2018 - 01/2016
2	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 12/2017 - 12/2016
2	Propafenone (Rythmol)FDA LinkGeneric 12/2017 - 08/2017
2	Materia Medica (Homeopathic Remedies)IBA 12/2017 - 08/2011
2	tyrosine receptor (receptor, tyrosine)IBA 11/2017 - 01/2017
2	Tyrosine Kinase InhibitorsIBA 01/2017 - 01/2017

Therapy/Procedure

15	Therapeutics 10/2021 - 01/2015
13	Drug Therapy (Chemotherapy) 01/2021 - 06/2008
11	Chinese Traditional Medicine (Traditional Chinese Medicine) 11/2021 - 01/2017
2	Radiotherapy 07/2019 - 01/2013
2	Aftercare (After-Treatment) 01/2019 - 06/2008